Amgen (AMGN) announced the presentation of new data across its rare disease portfolio and pipeline at the annual American College of ...

The Company reported a net loss of approximately $8.4 million, or $0.25 per share, for the three months ended September 30, 2024, compared to a net loss of approximately $11.3 million, or $0.48 per ...

Nuvectis Pharma CEO Says Increased Dose Intensity Needed To Drive More Efficacy From Ovarian Cancer Lead Drug Nuvectis Pharma, Inc. (NASDAQ: NVCT) stock is trading lower after the company reported ...

In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...

Nine San Franciscans in different phases of recovery from drug addictions are the new faces of public-health officials' ...

While not powered for statistical efficacy, the study showed promising trends favoring topical pravibismane plus standard of care (SoC) evaluating exploratory efficacy endpoints including complete ...

Last week, the US Food and Drug Administration (FDA) claimed that a core component in many popular nasal decongestants is ...

Kadimastem, the developer of the experimental amyotrophic lateral sclerosis (ALS) therapy AstroRx, is merging with NLS ...

That decision also was based on feedback from the U.S. Food and Drug Administration (FDA), and on the progress ... However, ...

Longboard Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that it has initiated its ...

College students have opportunities to bend or break the rules after leaving home. It can be dangerous for those who take ...